T. Kutluk Et Al. , "Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours," PEDIATRIC BLOOD & CANCER , vol.42, no.3, pp.284-286, 2004
Kutluk, T. Et Al. 2004. Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours. PEDIATRIC BLOOD & CANCER , vol.42, no.3 , 284-286.
Kutluk, T., Kurne, O., Akyuz, C., Ceyhan, M., Kanra, G., Buyukpamukcu, M., ... Secmeer, G.(2004). Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours. PEDIATRIC BLOOD & CANCER , vol.42, no.3, 284-286.
Kutluk, T Et Al. "Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours," PEDIATRIC BLOOD & CANCER , vol.42, no.3, 284-286, 2004
Kutluk, T Et Al. "Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours." PEDIATRIC BLOOD & CANCER , vol.42, no.3, pp.284-286, 2004
Kutluk, T. Et Al. (2004) . "Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours." PEDIATRIC BLOOD & CANCER , vol.42, no.3, pp.284-286.
@article{article, author={T Kutluk Et Al. }, title={Cefepime vs. meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours}, journal={PEDIATRIC BLOOD & CANCER}, year=2004, pages={284-286} }